CCM
Coldstream Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.62M | Buy |
5,874
+711
| +14% | +$317K | 0.04% | 222 |
|
|
2025
Q1 | $2.5M | Buy |
5,163
+267
| +5% | +$129K | 0.05% | 208 |
|
|
2024
Q4 | $1.97M | Buy |
4,896
+122
| +3% | +$49.1K | 0.04% | 246 |
|
|
2024
Q3 | $2.23M | Buy |
4,774
+552
| +13% | +$258K | 0.05% | 213 |
|
|
2024
Q2 | $1.98M | Buy |
4,222
+253
| +6% | +$119K | 0.05% | 210 |
|
|
2024
Q1 | $1.66M | Buy |
3,969
+38
| +1% | +$15.9K | 0.04% | 235 |
|
|
2023
Q4 | $1.6M | Buy |
3,931
+231
| +6% | +$94K | 0.04% | 216 |
|
|
2023
Q3 | $1.29M | Buy |
3,700
+86
| +2% | +$29.9K | 0.04% | 234 |
|
|
2023
Q2 | $1.27M | Buy |
3,614
+40
| +1% | +$14.1K | 0.04% | 237 |
|
|
2023
Q1 | $1.13M | Buy |
3,574
+209
| +6% | +$65.9K | 0.04% | 257 |
|
|
2022
Q4 | $972K | Buy |
+3,365
| New | +$972K | 0.04% | 270 |
|
|
2022
Q2 | $874K | Buy |
3,100
+473
| +18% | +$133K | 0.03% | 256 |
|
|
2022
Q1 | $686K | Buy |
2,627
+58
| +2% | +$15.1K | 0.02% | 296 |
|
|
2021
Q4 | $564K | Buy |
2,569
+1,212
| +89% | +$266K | 0.02% | 383 |
|
|
2021
Q3 | $369K | Buy |
1,357
+260
| +24% | +$70.7K | 0.02% | 286 |
|
|
2021
Q2 | $221K | Buy |
1,097
+28
| +3% | +$5.64K | 0.01% | 481 |
|
|
2021
Q1 | $230K | Sell |
1,069
-280
| -21% | -$60.2K | 0.01% | 387 |
|
|
2020
Q4 | $319K | Buy |
1,349
+215
| +19% | +$50.8K | 0.02% | 273 |
|
|
2020
Q3 | $308K | Buy |
1,134
+5
| +0.4% | +$1.36K | 0.03% | 234 |
|
|
2020
Q2 | $327K | Buy |
1,129
+20
| +2% | +$5.79K | 0.03% | 220 |
|
|
2020
Q1 | $263K | Buy |
1,109
+159
| +17% | +$37.7K | 0.03% | 220 |
|
|
2019
Q4 | $208K | Buy |
+950
| New | +$208K | 0.02% | 326 |
|